Showing results (1-10 of 497) with videos related to
Sort By:
Pageof 50
Hematological Oncology|June 15, 2025
Peripheral T-Cell Lymphoma: What's Next?Sang Eun Yoon, Won Seog KimInternational Journal of Hematology|November 19, 2010
Treatment of localized extranodal NK/T cell lymphoma, nasal typeSeok Jin Kim, Won Seog KimF1000Research|September 9, 2016
Evolution of frontline treatment of diffuse large B-cell lymphoma: a brief review and recent updateJung Yong Hong, Cheolwon Suh, Won Seog KimLeukemia & Lymphoma|February 1, 2013
Epstein-Barr virus latent membrane protein 1 increases genomic instability through Egr-1-mediated up-regulation of activation-induced cytidine deaminase in B-cell lymphomaJoo Hyun Kim, Won Seog Kim, Chaehwa ParkScientific Reports|March 22, 2024
Lysine demethylase LSD1 is associated with stemness in EBV-positive B cell lymphomaJoo Hyun Kim, Chaehwa Park, Won Seog KimVirchows Archiv : an International Journal of Pathology|October 18, 2005
Expression of CD56 antigen in Langerhans cell histiocytosis associated with T-lymphoblastic lymphoma in a same lymph nodeYoung-Hyeh Ko, Won-Seog Kim, Yoonjung KimLeukemia & Lymphoma|April 9, 2014
PKD1 is critical for Epstein-Barr virus LMP1-induced protection of malignant B cells from cell death induced by rituximabJoo Hyun Kim, Won Seog Kim, Chaehwa ParkBMC Cancer|October 12, 2019
Interleukin-6 mediates resistance to PI3K-pathway-targeted therapy in lymphomaJoo Hyun Kim, Won Seog Kim, Chaehwa ParkAntiviral Research|March 20, 2021
Sildenafil prevents HDACi-induced Epstein-Barr virus reactivation through the PKG pathway in NK/T cell lymphoma; potential implications for HDACi-mediated fatal complicationsJoo Hyun Kim, Won Seog Kim, Chaehwa ParkLeukemia & Lymphoma|January 25, 2012
Epstein-Barr virus latent membrane protein-1 protects B-cell lymphoma from rituximab-induced apoptosis through miR-155-mediated Akt activation and up-regulation of Mcl-1Joo Hyun Kim, Won Seog Kim, Chaehwa ParkPageof 50